 |
|
|
| |
|
|
|
|
|
|
Symposium program
|
Complete programPlease select a day:
 Expand All  Hide All  Printer friendly
|
|
|
|
|
|
EDU |
Thu 15 Nov
16:00 - 16:15 |
Opening Session |
|
|
|
Session Chair: Hakan Mellstedt, SE /
| Beginning |
Lecture title |
Speaker |
| 16:00 |
Welcome address |
Hakan Mellstedt, SE |
| 16:05 |
Welcome address |
Michael Papamichail, GR |
| 16:10 |
Welcome address |
John Wagstaff, GB |
|
EDU |
Thu 15 Nov
16:15 - 17:00 |
Keynote Lecture |
|
|
|
Session Chair: John Wagstaff, GB /
| Beginning |
Lecture title |
Speaker |
| 16:15 |
Cancer immunotherapy: how have we got to where we are now? |
John Wagstaff, GB |
|
EDU |
Thu 15 Nov
17:15 - 19:30 |
Cancer and inflammation |
|
|
|
Session Chair: Arjan W. Griffioen, NL / Session Co-Chair: Joachim Schultze, DE
| Beginning |
Lecture title |
Speaker |
| 17:15 |
The inflammatory tumour microenvironment and its impact on cancer development. |
Karin de Visser, NL |
| 17:45 |
Anti-angiogenic agents: the interface between the immune system and the tumor |
Arjan W. Griffioen, NL |
| 18:15 |
Regulatory T cells in cancer immunology and immunotherapy |
Joachim Schultze, DE |
| 18:45 |
Tumor induced immune suppression: role of oxidative stress |
Rolf Kiessling, SE |
| 19:15 |
Discussion |
|
|
EDU |
Fri 16 Nov
08:30 - 10:40 |
T cell immunity versus tolerance |
|
|
|
Session Chair: Thomas Blankenstein, DE / Session Co-Chair: Dmitry Gabrilovich, US
| Beginning |
Lecture title |
Speaker |
| 08:30 |
Measuring T cell responses |
Pedro Romero, CH |
| 09:00 |
Optimally expanding T cells in a tumor environment |
Robert Hawkins, GB |
| 09:30 |
Combining chemotherapy with immunotherapy |
Dmitry Gabrilovich, US |
| 10:00 |
Breaking tolerance |
Thomas Blankenstein, DE |
| 10:30 |
Discussion |
|
|
EDU |
Fri 16 Nov
11:00 - 13:10 |
Antibodies |
|
|
|
Session Chair: Hakan Mellstedt, SE / Session Co-Chair: Carl Borrebaeck, SE
| Beginning |
Lecture title |
Speaker |
| 11:00 |
Antibody technology in clinical oncology |
Carl Borrebaeck, SE |
| 11:30 |
Individual idiotype vaccines in hematological malignancies |
Hakan Mellstedt, SE |
| 12:00 |
HER-2neu vaccines for breast, ovarian and prostate cancers |
George Peoples, US |
| 12:30 |
Future developments in antibody based therapies |
Jan van de Winkel, NL |
| 13:00 |
Discussion |
|
|
EDU |
Fri 16 Nov
14:10 - 16:20 |
Vaccines I |
|
|
|
Session Chair: Rik Scheper, NL / Session Co-Chair: Angus Dalgleish, GB
| Beginning |
Lecture title |
Speaker |
| 14:10 |
Antigen discovery |
Pierre Coulie, BE |
| 14:40 |
Adjuvants |
Hyam I. Levitsky, US |
| 15:10 |
Lung, prostate and colorectal vaccines: how far are we from registration? |
Angus Dalgleish, GB |
| 15:40 |
Protein/peptide vaccines in melanoma |
Daniel Speiser, CH |
| 16:10 |
Discussion |
|
|
EDU |
Fri 16 Nov
16:35 - 17:20 |
Keynote Lecture |
|
|
|
Session Chair: John Wagstaff, GB /
| Beginning |
Lecture title |
Speaker |
| 16:35 |
Tumor immunology: Back to the future |
Cornelis Melief, NL |
|
EDU |
Sat 17 Nov
09:00 - 10:40 |
Adoptive Immunotherapy |
|
|
|
Session Chair: Michael Papamichail, GR / Session Co-Chair: Hans-Gustaf Ljunggren, SE
| Beginning |
Lecture title |
Speaker |
| 09:00 |
NK cell activation and tumor recognition |
Hans-Gustaf Ljunggren, SE |
| 09:30 |
Prospects for adoptive NK cell therapy of human cancer |
Karl Johan Malmberg, SE |
| 10:00 |
Graft versus tumor and donor lymphocyte infusions |
Shimon Slavin, IL |
| 10:30 |
Discussion |
|
|
EDU |
Sat 17 Nov
11:00 - 13:15 |
Vaccines II |
|
|
|
Session Chair: Carl Figdor, NL / Session Co-Chair: Rik Scheper, NL
| Beginning |
Lecture title |
Speaker |
| 11:00 |
Dendritic cell vaccines |
Carl Figdor, NL |
| 11:30 |
Whole cell vaccines |
Rik Scheper, NL |
| 12:00 |
Viral and vector vaccines |
Joerg Schneider, FR |
| 12:30 |
Old problems, new directions |
Eli Gilboa, US |
|
| |
|
|
|
|
|
|
|
|
| |
|
 |
 |
|
|
|
